semaglutide drugs list Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries List of approved and pending

Retatrutide is the first triple-receptor agonist ever developed, activating GLP-1, GIP, and glucagon receptors simultaneously

Stimulates insulin release and suppresses glucagon secretion

Consider asking your provider about: timing of doses relative to feeding sessions, monitoring plans for infant feeding tolerance, alternative treatments if GLP-1 is deemed higher-risk, and ongoing follow-up if you choose to continue

Moreover, in DNA methylation alterations of tumor cells induced by GLP-1RAs, studies have demonstrated that during breast cancer progression, tumor suppressor genes such as ESR1, CDH1, and ADAM33 are downregulated due to hypermethylation alterations in their promoter regions